New logo 2022

Radius Health, Inc. is a global biopharmaceutical company dedicated to addressing unmet medical needs in the areas of bone health and related therapeutic fields. Founded in 2003, the company focuses on the development and commercialization of innovative endocrine therapeutics. Radius Health is committed to delivering scientific innovation and transformative solutions that improve the lives of patients, their caregivers, and the broader healthcare community. The company's lead product, TYMLOS® (abaloparatide) injection, is an FDA-approved treatment for postmenopausal women with osteoporosis at high risk for fracture, as well as for men with osteoporosis at high risk for fracture.

Headquartered in Boston, Massachusetts, Radius Health operates with a mission to transform the future for underserved patient populations. The organization emphasizes a patient-centric approach, ensuring that its research and development efforts are aligned with the real-world needs of those suffering from bone health conditions. In addition to its commercial products, Radius Health continues to explore new therapeutic opportunities and expand its portfolio through strategic partnerships and internal development. The company fosters a culture of excellence, integrity, and collaboration, employing a dedicated team of professionals who work relentlessly to advance medical science and improve patient outcomes.